12-05-2021 | Oncology | Highlight | Article
COVID-19 leaves large cancer screening deficit in USA
Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.
26-11-2020 | Oncology | News | Article
Oligometastatic cancer outcomes acceptable with SABR
Stereotactic ablative radiotherapy is associated with “clinically acceptable” rates of toxicity, local control, progression-free survival, and overall survival in people with oligometastatic cancer, meta-analysis data suggest.
12-03-2020 | Oncology | News | Article
Metastases progression linked to deteriorating HRQoL
Disease progression among patients with metastatic lung, pancreatic, colorectal, and breast cancer is associated with statistically significant and clinically relevant reductions in health-related quality of life, real-world study data show.
29-06-2018 | Colorectal cancer | News | Article
In other news: CRC and surveillance
We cover three studies of colorectal cancer surveillance, one evaluating the relationship between adenomas at colonoscopy and the long-term incidence of cancer, while the other two investigate whether higher-intensity post-surgery follow-up improves outcomes.
02-06-2018 | Colorectal cancer | News | Article
Metastatic CRC cost disparity revealed for USA, Canada
The cost of metastatic colorectal cancer treatment in the USA is significantly more expensive than in Canada but does not achieve a greater survival benefit among patients, highlight findings reported at the ASCO Annual Meeting 2018 in Chicago, Illinois, USA.
USA outline_flag/© Image by Gordon Johnson from Pixabay, Man receiving radiotherapy/© Mediteraneo / Fotolia, HIPEC surgery/© Davorin Wagner / Chirurgie im Bild